These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 11549586)

  • 61. Role of cellular prion protein in interneuronal amyloid transmission.
    Del Río JA; Ferrer I; Gavín R
    Prog Neurobiol; 2018; 165-167():87-102. PubMed ID: 29530723
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Neuronal intranuclear inclusion disease without polyglutamine inclusions in a child.
    McFadden K; Hamilton RL; Insalaco SJ; Lavine L; Al-Mateen M; Wang G; Wiley CA
    J Neuropathol Exp Neurol; 2005 Jun; 64(6):545-52. PubMed ID: 15977647
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Rifampicin is a candidate preventive medicine against amyloid-β and tau oligomers.
    Umeda T; Ono K; Sakai A; Yamashita M; Mizuguchi M; Klein WL; Yamada M; Mori H; Tomiyama T
    Brain; 2016 May; 139(Pt 5):1568-86. PubMed ID: 27020329
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Detection and Imaging of Aβ1-42 and Tau Fibrils by Redesigned Fluorescent X-34 Analogues.
    Zhang J; Sandberg A; Konsmo A; Wu X; Nyström S; Nilsson KPR; Konradsson P; LeVine H; Lindgren M; Hammarström P
    Chemistry; 2018 May; 24(28):7210-7216. PubMed ID: 29543355
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Characterization of amyloid deposits in neurodegenerative diseases.
    Vidal R; Ghetti B
    Methods Mol Biol; 2011; 793():241-58. PubMed ID: 21913105
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Ligand electronic properties modulate tau filament binding site density.
    Cisek K; Jensen JR; Honson NS; Schafer KN; Cooper GL; Kuret J
    Biophys Chem; 2012; 170():25-33. PubMed ID: 23072817
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Control tissue in brain banking: the importance of thorough neuropathological assessment.
    Nolan M; Troakes C; King A; Bodi I; Al-Sarraj S
    J Neural Transm (Vienna); 2015 Jul; 122(7):949-56. PubMed ID: 25673433
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Intracellular Thermometry at the Micro-/Nanoscale and its Potential Application to Study Protein Aggregation Related to Neurodegenerative Diseases.
    Chung CW; Kaminski Schierle GS
    Chembiochem; 2021 May; 22(9):1546-1558. PubMed ID: 33326160
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Mechanisms of neurodegenerative disorders: Part 1: protein aggregates.
    Wolozin B; Behl C
    Arch Neurol; 2000 Jun; 57(6):793-6. PubMed ID: 10867775
    [No Abstract]   [Full Text] [Related]  

  • 70. Development of positron emission tomography β-amyloid plaque imaging agents.
    Mathis CA; Mason NS; Lopresti BJ; Klunk WE
    Semin Nucl Med; 2012 Nov; 42(6):423-32. PubMed ID: 23026364
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Pharmacotherapies for the Treatment of Progressive Supranuclear Palsy: A Narrative Review.
    Dunning EE; Decourt B; Zawia NH; Shill HA; Sabbagh MN
    Neurol Ther; 2024 Aug; 13(4):975-1013. PubMed ID: 38743312
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Evaluation and Characterization of Modified K114 Method to Localize Plaques in Rodent and Plaques and Tangles in Human Brain Tissue.
    Padala S; Setti S; Raymick J; Hanig J; Sarkar S
    Curr Alzheimer Res; 2024; 21(1):69-80. PubMed ID: 38566375
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Thioflavin S Staining and Amyloid Formation Are Unique to Mixed Tauopathies.
    Fiock KL; Betters RK; Hefti MM
    J Histochem Cytochem; 2023 Feb; 71(2):73-86. PubMed ID: 36861683
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Dual-probe fluorescence spectroscopy for sensitive quantitation of Alzheimer's amyloid pathology.
    Stepanchuk AA; Morgan ML; Joseph JT; Stys PK
    Acta Neuropathol Commun; 2022 Oct; 10(1):153. PubMed ID: 36307888
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Isoform-specific patterns of tau burden and neuronal degeneration in MAPT-associated frontotemporal lobar degeneration.
    Giannini LAA; Ohm DT; Rozemuller AJM; Dratch L; Suh E; van Deerlin VM; Trojanowski JQ; Lee EB; van Swieten JC; Grossman M; Seelaar H; Irwin DJ;
    Acta Neuropathol; 2022 Dec; 144(6):1065-1084. PubMed ID: 36066634
    [TBL] [Abstract][Full Text] [Related]  

  • 76. An autophagy enhancer ameliorates diabetes of human IAPP-transgenic mice through clearance of amyloidogenic oligomer.
    Kim J; Park K; Kim MJ; Lim H; Kim KH; Kim SW; Lee ES; Kim HH; Kim SJ; Hur KY; Kim JH; Ahn JH; Yoon KH; Kim JW; Lee MS
    Nat Commun; 2021 Jan; 12(1):183. PubMed ID: 33420039
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Progressive supranuclear palsy: Advances in diagnosis and management.
    Coughlin DG; Litvan I
    Parkinsonism Relat Disord; 2020 Apr; 73():105-116. PubMed ID: 32487421
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Structure and Aggregation Mechanisms in Amyloids.
    Almeida ZL; Brito RMM
    Molecules; 2020 Mar; 25(5):. PubMed ID: 32155822
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A KLVFFAE-Derived Peptide Probe for Detection of Alpha-Synuclein Fibrils.
    Wood A; Chau E; Yang Y; Kim JR
    Appl Biochem Biotechnol; 2020 Apr; 190(4):1411-1424. PubMed ID: 31776941
    [TBL] [Abstract][Full Text] [Related]  

  • 80. 4',6-Diamidino-2-Phenylindole Distinctly Labels Tau Deposits.
    Li C; Takahashi T; Shrestha T; Kinoshita E; Matsubara T; Matsumoto M; Maruyama H
    J Histochem Cytochem; 2018 Oct; 66(10):737-751. PubMed ID: 30106598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.